Scholars Central

Case reportPublished 30 Oct 2018

Whole transcriptome analysis identifies upregulated genes and pathways in ductal carcinoma in situ mimicking usual ductal hyperplasia

Authors: Jennifer Zeng, Jonathan Serrano, Matija Snuderl, Farbod Darvishian

Histology and Histopathology Research

Volume 2 · Issue 2 · Pages 36–38

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Ductal carcinoma in situ (DCIS) and usual ductal hyperplasia (UDH) represent two extremes on the spectrum of intraductal proliferative lesions of the breast with corresponding differences in invasive carcinoma risk, molecular alteration and therapeutic management. In cases with overlapping morphology, the distinction between DCIS and UDH can be challenging. We performed whole transcriptome analysis on laser-capture microdissected samples from formalin-fixed, paraffin-embedded (FFPE) tissue in two cases of DCIS with UDH-like morphology (DUM) and their corresponding UDH. Of the top 10 genes differentially up/down regulated in DUM compared to UDH, we selected cyclin D1 (upregulated in DUM) and CD117 (c-kit) (down regulated in DUM) and performed immunohistochemical studies using clinically validated antibodies for cyclin D1 and CD117, respectively. Our results showed that both DUM lesions showed strong and diffuse (>50%) nuclear positivity for cyclin D1 antibody. The corresponding foci of UDH showed no reactivity to weak and sparse (<1%) staining for cyclin D1 antibody. Conversely, UDH expressed patchy CD117 (c-kit) positivity, while DUM lesion was completely negative. We also demonstrated that DUM lesions are enriched for genes associated with invasive ducal carcinoma, luminal subtype and brain metastasis. In summary, despite morphological similarities, DUM and UDH are molecularly distinct. Our study showed that whole transcriptome analysis of morphologically distinct lesions from the same FFPE sample isolated by laser capture microdissection provides a powerful tool to identify novel biomarkers in breast cancer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Histology and Histopathology Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalHistology and Histopathology Research
  • SubjectPathology & Lab Medicine
  • BylineArticles whose byline prints “Jennifer Zeng”
  • BylineArticles whose byline prints “Jonathan Serrano”
  • BylineArticles whose byline prints “Matija Snuderl”
  • BylineArticles whose byline prints “Farbod Darvishian”